TearSolutions: Naturally Treating Dry Eye (225)

Episode 25 • July 04, 2022 • 00:23:20
TearSolutions: Naturally Treating Dry Eye (225)
Innovation4Alpha
TearSolutions: Naturally Treating Dry Eye (225)

Jul 04 2022 | 00:23:20

/

Show Notes

TearSolutions' lead product, called Lacripep, delivers what no other approved or pipeline drug has been able to: rapid healing of the ocular surface and relief of dry eye symptoms with a best-in-class safety and comfort profile. This was all proven in their first-in-human clinical trial which has led to formal written FDA alignment on our clinical and regulatory path to an unrestricted general Dry Eye indication (which is the same path a dry eye drug called Xiidra took, which sold to Novartis for $5.3B). 

The company is raising capital to get Lacripep back into the clinic for the first of two Phase III trials.

Other Episodes

Episode 5

February 09, 2022 • 00:43:54
Episode Cover

Jaffar Raza, MD - Opportunities, Cost Management and Technology (205)

Jaffar Raza, MD is a board certified Interventional Cardiologist affiliated with Lenox Hill, Hackensack and Holy name hospitals. He completed his residency in Internal...

Listen

Episode 6

December 15, 2023 • 00:33:36
Episode Cover

Petra Capital Properties

Petra Capital Properties is a mission-based real estate investment management company dedicated to serving their clients with high quality real estate investment opportunities with...

Listen

Episode 14

July 28, 2021 • 00:35:12
Episode Cover

Featured Family Office / Incubator: Hall Venture Partners (014)

Hall Venture Partners is located at a state-of-the-art Hall Labs innovation campus in Provo, Utah. Hall Venture Partners was established to address the growing...

Listen